Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,410,581 | 4,410,581 | 0 | 69,246 | 77,626 | 62.70% | +8,380 |
| Lyell Immunopharma, Inc. | 0 | 800,399 | +800,399 | 0 | 7,076 | 5.72% | +7,076 |
| Xenon Pharmaceuticals Inc(XENE) | 0 | 160,000 | +160,000 | 0 | 5,008 | 4.05% | +5,008 |
| Maze Therapeutics Inc(MAZE) | 2,111,919 | 2,111,919 | 0 | 23,252 | 25,913 | 20.93% | +2,661 |
| Relay Therapeutics Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | 2,620 | 3,460 | 2.79% | +840 |
| Kura Oncology, Inc.(KURA) | 1,111,882 | 816,882 | -295,000 | 7,338 | 4,713 | 3.81% | -2,625 |
| Lyell Immunopharma, Inc. | 16,007,999 | 0 | -16,007,999 | 8,612 | 0 | — | -8,612 |